Why $ANCN Anchiano Therapeutics Is Surging Today?
Thanks to some news in December in the biopharma space, $ANCN stock is racing higher. So what was that news? And what else do you need to know?
$ANCN Anchiano Therapeutics is captivating investors thanks to its Definitive Merger Agreement with Chemomab news in december.
The proposed merger will create a public company focused on advancing Chemomab’s lead product, CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant unmet medical need
Concurrent PIPE financing to be used to fund clinical trials for CM-101 in fibrotic indications, focusing on two rare diseases and backed by leading healthcare-focused investors OrbiMed and Peter Thiel.
Concurrent with the merger, Chemomab seeks to complete a PIPE financing to advance CM-101 into Phase 2 clinical trials in rare fibrotic indications, as well as to further develop Chemomab’s earlier-stage pipeline.
We intend to hold a special meeting of Anchiano’s shareholders in the first quarter of 2021 to vote on this merger."
finance.yahoo.com/ne...entry-140000055.html
Thanks to some news in December in the biopharma space, $ANCN stock is racing higher. So what was that news? And what else do you need to know?
$ANCN Anchiano Therapeutics is captivating investors thanks to its Definitive Merger Agreement with Chemomab news in december.
The proposed merger will create a public company focused on advancing Chemomab’s lead product, CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant unmet medical need
Concurrent PIPE financing to be used to fund clinical trials for CM-101 in fibrotic indications, focusing on two rare diseases and backed by leading healthcare-focused investors OrbiMed and Peter Thiel.
Concurrent with the merger, Chemomab seeks to complete a PIPE financing to advance CM-101 into Phase 2 clinical trials in rare fibrotic indications, as well as to further develop Chemomab’s earlier-stage pipeline.
We intend to hold a special meeting of Anchiano’s shareholders in the first quarter of 2021 to vote on this merger."
finance.yahoo.com/ne...entry-140000055.html